Skip to content

Welcome to Discover Pharma! Today is : October 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

early cancer detection

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Leicester clinic offers Galleri blood test following NHS cancer trial

    A Leicester private GP clinic has begun offering Galleri, a [...]

    August 24, 2026
  • Clinical & Regulatory,Digital & Data,Therapeutic Areas

    SpotitEarly partners with Fox Chase Cancer Center to advance breath-based cancer detection trials

    SpotitEarly has entered into a strategic research partnership with Fox [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Opinion & Events,Therapeutic Areas

    SpotitEarly and Hackensack Meridian Health partner to advance early detection with trained dogs

    SpotitEarly, a US-based early cancer detection startup, has announced a [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Mainz Biomed targets US approval for next-gen CRC test and expands into pancreatic cancer

    Mainz Biomed says it is preparing to launch a pivotal [...]

    May 5, 2026
  • Drug Discovery & Development,Therapeutic Areas

    Mainz Biomed launches feasibility study to assess pancreatic cancer biomarker panel

    Mainz Biomed has initiated a feasibility study as part of [...]

    May 5, 2026
  • Drug Discovery & Development,Opinion & Events,Uncategorised

    SpotitEarly targets US market with AI-canine breath test for early cancer detection

    A biotech company combining artificial intelligence with canine scent detection [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Novadip secures €10.4M to advance pivotal Phase 3 trial
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Telix to acquire ITM in $1.65BN radiopharmaceutical deal
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top